A comprehensive view of Illnesses / Symptoms / Conditions. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlobalData: Drug repurposing using AI gaining traction in pharmaceutical industry while boosting success rate of clinical development trials; process will eventually provide patients with faster access to new treatments, answers to rare disease symptoms
Published: February 13, 2023 by Express Pharma (India)
Nearly half of California's cancer deaths between 2017-2019 were associated with tobacco use, higher than previously reported, according to UC Davis study; however, study shows some decline in cancer deaths compared to 2014-2016 period
Published: December 28, 2022 by Cancer Daily
Pfizer, partnering with Sosei Group, announces dosing of first subject in Phase 2 clinical trial of PF-07081532, a candidate for treatment of type 2 diabetes and obesity; trial marks a development milestone, triggering US$10M payment to Sosei
Published: December 21, 2022 by Globe Newswire
Seagen, Astellas and Merck announce FDA has accepted biologics license applications for PADCEV and KEYTRUDA for first-line treatment of certain urothelial cancers
Published: December 21, 2022 by ENP Newswire
Roche announces FDA approval of Actemra intravenous infusion for treatment of COVID-19 in hospitalized adults; product is first monoclonal antibody approved by the FDA for COVID-19
Published: December 21, 2022 by GlobeNewswire Europe

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count